In vivo evaluation of the dual MOP/NOP agonist AT121: a potent analgesic that delays opioid tolerance and offers a superior withdrawal suppression profile to methadone

👤 Baraa E. Elawy; Loai Aljerf; Shaza A. Allaham; Georges M. Deeb 🗓️ 2026

المصدر: Neuroscience